User menu

Seasonal variation of relapse rate in multiple sclerosis is latitude dependent

Bibliographic reference Spelman, Tim ; Gray, Orla ; Trojano, Maria ; Petersen, Thor ; Izquierdo, Guillermo ; et. al. Seasonal variation of relapse rate in multiple sclerosis is latitude dependent. In: Annals of Neurology, Vol. 76, no.6, p. 880-890 (2014)
Permanent URL http://hdl.handle.net/2078.1/153420
  1. Simpson S., Blizzard L., Otahal P., Van der Mei I., Taylor B., Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis, 10.1136/jnnp.2011.240432
  2. Risco J, Maldonado H, Luna L, Osada J, Ruiz P, Juarez A, Vizcarra D, Latitudinal prevalence gradient of multiple sclerosis in Latin America, 10.1177/1352458511405562
  3. Hollingworth Samantha, Walker Kimitra, Page Andrew, Eadie Mervyn, Pharmacoepidemiology and the Australian regional prevalence of multiple sclerosis, 10.1177/1352458513482371
  4. Ascherio Alberto, Munger Kassandra L., Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors : Environmental Risk Factors for MS, 10.1002/ana.21141
  5. Simpson, Ann Neurol, 68, 193 (2010)
  6. Lucas Robyn M., Ponsonby Anne-Louise, Dear Keith, Valery Patricia C., Taylor Bruce, van der Mei Ingrid, McMichael Anthony J., Pender Michael P., Chapman Caron, Coulthard Alan, Kilpatrick Trevor J., Stankovich Jim, Williams David, Dwyer Terence, Vitamin D status: Multifactorial contribution of environment, genes and other factors in healthy Australian adults across a latitude gradient, 10.1016/j.jsbmb.2013.01.011
  7. Kampman Margitta T., Brustad Magritt, Vitamin D: A Candidate for the Environmental Effect in Multiple Sclerosis – Observations from Norway, 10.1159/000122330
  8. Mowry, Ann Neurol, 72, 234 (2012)
  9. Jin Ya-Ping, de Pedro-Cuesta Jesús, Söderström Mats, Stawiarz Leszek, Link Hans, Seasonal patterns in optic neuritis and multiple sclerosis: a meta-analysis, 10.1016/s0022-510x(00)00408-1
  10. Bamford C. R., Sibley W. A., Thies C., Seasonal variation of multiple sclerosis exacerbations in Arizona, 10.1212/wnl.33.6.697
  11. Bisgard, Ugeskr Laeger, 152, 1160 (1990)
  12. Callaghan T.S., MULTIPLE SCLEROSIS AND SINUSITIS, 10.1016/s0140-6736(86)91970-7
  13. Gay Derek, Dick George, Upton Graham, MULTIPLE SCLEROSIS ASSOCIATED WITH SINUSITIS: CASE-CONTROLLED STUDY IN GENERAL PRACTICE, 10.1016/s0140-6736(86)90936-0
  14. Goodkin D. E., Hertsgaard D., Seasonal Variation of Multiple Sclerosis Exacerbations in North Dakota, 10.1001/archneur.1989.00520450085025
  15. Hopkins, Arch Neurol, 74, 203 (1955)
  16. O’Reilly Mary A.R., O’Reilly Peter M.R., Temporal Influences on Relapses of Multiple Sclerosis, 10.1159/000116701
  17. Schapira K., THE SEASONAL INCIDENCE OF ONSET AND EXACERBATIONS IN MULTIPLE SCLEROSIS, 10.1136/jnnp.22.4.285
  18. Sibley, Trans Am Neurol Assoc, 90, 295 (1965)
  19. Sosa Enriguez, Arch Neurobiol (Madr), 46, 161 (1983)
  20. Abella-Corral, Rev Neurol, 40, 394 (2005)
  21. Ogawa G., Mochizuki H., Kanzaki M., Kaida K., Motoyoshi K., Kamakura K., Seasonal variation of multiple sclerosis exacerbations in Japan, 10.1007/s10072-003-0200-5
  22. Koziol James A., Feng Anne C., Seasonal Variations in Exacerbations and MRI Parameters in Relapsing- Remitting Multiple Sclerosis, 10.1159/000079946
  23. Butzkueven H, Chapman J, Cristiano E, Grand’Maison F, Hoffmann M, Izquierdo G, Jolley D, Kappos L, Leist T, Pöhlau D, Rivera V, Trojano M, Verheul F, Malkowski J-P, MSBase: an international, online registry and platform for collaborative outcomes research in multiple sclerosis, 10.1177/1352458506070775
  24. Poser Charles M., Paty Donald W., Scheinberg Labe, McDonald W. Ian, Davis Floyd A., Ebers George C., Johnson Kenneth P., Sibley William A., Silberberg Donald H., Tourtellotte Wallace W., New diagnostic criteria for multiple sclerosis: Guidelines for research protocols, 10.1002/ana.410130302
  25. McDonald W. Ian, Compston Alistair, Edan Gilles, Goodkin Donald, Hartung Hans-Peter, Lublin Fred D., McFarland Henry F., Paty Donald W., Polman Chris H., Reingold Stephen C., Sandberg-Wollheim Magnhild, Sibley William, Thompson Alan, Van Den Noort Stanley, Weinshenker Brian Y., Wolinsky Jerry S., Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis, 10.1002/ana.1032
  26. http://iridl.ldeo.columbia.edu/SOURCES/.NASA/.GSFC/.TOMS 2013
  27. Stolwijk A. M., Straatman H., Zielhuis G. A., Studying seasonality by using sine and cosine functions in regression analysis, 10.1136/jech.53.4.235
  28. Holick Michael F., Vitamin D Deficiency, 10.1056/nejmra070553
  29. F. Holick Michael, Vitamin D: Evolutionary, Physiological and Health Perspectives, 10.2174/138945011793591635
  30. Hagenau T., Vest R., Gissel T. N., Poulsen C. S., Erlandsen M., Mosekilde L., Vestergaard P., Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: an ecologic meta-regression analysis, 10.1007/s00198-008-0626-y
  31. Pierrot-Deseilligny Charles, Souberbielle Jean-Claude, Widespread vitamin D insufficiency: A new challenge for primary prevention, with particular reference to multiple sclerosis, 10.1016/j.lpm.2011.01.003
  32. Shoben A. B., Kestenbaum B., Levin G., Hoofnagle A. N., Psaty B. M., Siscovick D. S., de Boer I. H., Seasonal Variation in 25-Hydroxyvitamin D Concentrations in the Cardiovascular Health Study, 10.1093/aje/kwr258
  33. Mowry, Ann Neurol, 67, 618 (2010)
  34. Pierrot-Deseilligny Charles, Rivaud-Péchoux Sophie, Clerson Pierre, de Paz Raphaël, Souberbielle Jean-Claude, Relationship between 25-OH-D serum level and relapse rate in multiple sclerosis patients before and after vitamin D supplementation, 10.1177/1756285612447090
  35. Auer Dorothee P., Schumann Erina M., K�mpfel Tania, G�ssl Christoff, Trenkwalder Claudia, Seasonal fluctuations of gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis, 10.1002/1531-8249(200002)47:2<276::aid-ana28>3.0.co;2-1
  36. Mowry Ellen M., Waubant Emmanuelle, McCulloch Charles E., Okuda Darin T., Evangelista Alan A., Lincoln Robin R., Gourraud Pierre-Antoine, Brenneman Don, Owen Mary C., Qualley Pamela, Bucci Monica, Hauser Stephen L., Pelletier Daniel, Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis, 10.1002/ana.23591
  37. Zivadinov Robert, Treu Cierra N, Weinstock-Guttman Bianca, Turner Caitlin, Bergsland Niels, O'Connor Kerri, Dwyer Michael G, Carl Ellen, Ramasamy Deepa P, Qu Jun, Ramanathan Murali, Interdependence and contributions of sun exposure and vitamin D to MRI measures in multiple sclerosis, 10.1136/jnnp-2012-304661
  38. Eccles R., An Explanation for the Seasonality of Acute Upper Respiratory Tract Viral Infections, 10.1080/00016480252814207
  39. LONDON WAYNE P., YORKE JAMES A., RECURRENT OUTBREAKS OF MEASLES, CHICKENPOX AND MUMPS, 10.1093/oxfordjournals.aje.a121575
  40. BRISSON M., EDMUNDS W. J., LAW B., GAY N. J., WALLD R., BROWNELL M., ROOS L., DE SERRES G., Epidemiology of varicella zoster virus infection in Canada and the United Kingdom, 10.1017/s0950268801005921
  41. Sabetta James R., DePetrillo Paolo, Cipriani Ralph J., Smardin Joanne, Burns Lillian A., Landry Marie L., Serum 25-Hydroxyvitamin D and the Incidence of Acute Viral Respiratory Tract Infections in Healthy Adults, 10.1371/journal.pone.0011088
  42. SIBLEY W, CLINICAL VIRAL INFECTIONS AND MULTIPLE SCLEROSIS, 10.1016/s0140-6736(85)92801-6
  43. Andersen Oluf, Lygner Per-Erik, Bergstr�m Tomas, Andersson Mats, Vablne Anders, Viral infections trigger multiple sclerosis relapses: a prospective seroepidemiological study, 10.1007/bf00867354
  44. Panitch Hillel S., Influence of infection on exacerbations of multiple sclerosis, 10.1002/ana.410360709
  45. Edwards S, Zvartau M, Clarke H, Irving W, Blumhardt L D, Clinical relapses and disease activity on magnetic resonance imaging associated with viral upper respiratory tract infections in multiple sclerosis, 10.1136/jnnp.64.6.736
  46. Smith K. J., McDonald W. I., The pathophysiology of multiple sclerosis  the mechanisms underlying the production of symptoms and the natural history of the disease, 10.1098/rstb.1999.0510
  47. Buljevac D., Flach H. Z., Hop W. C. J., Hijdra D., Laman J. D., Savelkoul H. F. J., van der Meché F. G. A., van Doorn P. A., Hintzen R. Q., Prospective study on the relationship between infections and multiple sclerosis exacerbations, 10.1093/brain/awf098
  48. Hart Prue H., Gorman Shelley, Finlay-Jones John J., Modulation of the immune system by UV radiation: more than just the effects of vitamin D?, 10.1038/nri3045
  49. Lemire, J Nutr, 125, 1704S (1995)
  50. TSOUKAS CONSTANTINE D., WATRY DEBBIE, ESCOBAR SABINE S., PROVVEDINI DIEGO M., DINARELLO CHARLES A., HUSTMYER FRANK G., MANOLAGAS STAVROS C., Inhibition of Interleukin-1 Production by 1,25-Dihydroxyvitamin D3, 10.1210/jcem-69-1-127
  51. Lemire Jacques M., Immunomodulatory actions of 1,25-Dihydroxyvitamin D3, 10.1016/0960-0760(95)00106-a
  52. Etten Evelyne van, Mathieu Chantal, Immunoregulation by 1,25-dihydroxyvitamin D3: Basic concepts, 10.1016/j.jsbmb.2005.06.002
  53. Tsoukas C., Provvedini D., Manolagas S., 1,25-dihydroxyvitamin D3: a novel immunoregulatory hormone, 10.1126/science.6427926
  54. Smolders J, Menheere P, Kessels A, Damoiseaux J, Hupperts R, Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis, 10.1177/1352458508094399
  55. PROVVEDINI DIEGO M., MANOLAGAS STAVROS C., 1α,25-Dihydroxyvitamin D3Receptor Distribution and Effects in Subpopulations of Normal Human T Lymphocytes*, 10.1210/jcem-68-4-774
  56. Provvedini, J Immunol, 136, 2734 (1986)
  57. Lemire J M, Archer D C, 1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis., 10.1172/jci115072
  58. Cantorna M. T., Hayes C. E., DeLuca H. F., 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis., 10.1073/pnas.93.15.7861
  59. Pedersen Laura B., Nashold Faye E., Spach Karen M., Hayes Colleen E., 1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by inhibiting chemokine synthesis and monocyte trafficking, 10.1002/jnr.21382
  60. Ng R. L. X., Bisley J. L., Gorman S., Norval M., Hart P. H., Ultraviolet Irradiation of Mice Reduces the Competency of Bone Marrow-Derived CD11c+ Cells via an Indomethacin-Inhibitable Pathway, 10.4049/jimmunol.1001693
  61. Norval Mary, Halliday Gary M., The Consequences of UV-Induced Immunosuppression for Human Health : Photochemistry and Photobiology, 10.1111/j.1751-1097.2011.00969.x
  62. Kalinski P., Regulation of Immune Responses by Prostaglandin E2, 10.4049/jimmunol.1101029
  63. Norval Mary, Woods Gregory M., UV-induced immunosuppression and the efficacy of vaccination, 10.1039/c1pp05105a
  64. Soilu-Hänninen Merja, Åivo Julia, Lindström Britt-Marie, Elovaara Irina, Sumelahti Marja-Liisa, Färkkilä Markus, Tienari Pentti, Atula Sari, Sarasoja Taneli, Herrala Lauri, Keskinarkaus Irma, Kruger Johanna, Kallio Timo, Rocca Maria A, Filippi Massimo, A randomised, double blind, placebo controlled trial with vitamin D3as an add on treatment to interferon β-1b in patients with multiple sclerosis, 10.1136/jnnp-2011-301876
  65. Derakhshandi Hajar, Etemadifar Masoud, Feizi Awat, Abtahi Seyed-Hossein, Minagar Alireza, Abtahi Mohammad-Ali, Abtahi Zahra-Alsadat, Dehghani Alireza, Sajjadi Sepideh, Tabrizi Nasim, Preventive effect of vitamin D3 supplementation on conversion of optic neuritis to clinically definite multiple sclerosis: a double blind, randomized, placebo-controlled pilot clinical trial, 10.1007/s13760-012-0166-2
  66. Stein M. S., Liu Y., Gray O. M., Baker J. E., Kolbe S. C., Ditchfield M. R., Egan G. F., Mitchell P. J., Harrison L. C., Butzkueven H., Kilpatrick T. J., A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis, 10.1212/wnl.0b013e3182343274
  67. Smolders Joost, Hupperts Raymond, Barkhof Frederik, Grimaldi Luigi M.E., Holmoy Trygve, Killestein Joep, Rieckmann Peter, Schluep Myriam, Vieth Reinhold, Hostalek Ulrike, Ghazi-Visser Lizette, Beelke Manolo, Efficacy of vitamin D3 as add-on therapy in patients with relapsing–remitting multiple sclerosis receiving subcutaneous interferon beta-1a: A Phase II, multicenter, double-blind, randomized, placebo-controlled trial, 10.1016/j.jns.2011.04.013